Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • Upcoming Pharma City...

    Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-09-20T14:33:43+05:30  |  Updated On 20 Sept 2019 2:33 PM IST
    Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

    The Hyderabad Pharma City project has received an overwhelming response from the industry stakeholders, Telangana Minister for IT and Industries KT Rama Rao said. He was responding to a query in the state assembly.


    Hyderabad: The Telangana government on Thursday said the proposed Pharma City near here is expected to generate investments worth Rs 64,000 crore and provide direct and indirect employment to 5.60 lakh people.


    The Hyderabad Pharma City project has received an overwhelming response from the industry stakeholders, Telangana Minister for IT and Industries KT Rama Rao said. He was responding to a query in the state assembly.


    Over 100 large industries and about 200 MSMEs have submitted an expression of interest to establish their units across the value chain of pharmaceuticals including Research and Development, Active Pharmaceutical Ingredients, biological manufacturing among others, Rao noted.


    Read Also: Elbrit Life Sciences to expand production capacity with over Rs 13 crore investment


    The project would enable creations of employment opportunities for skilled, semi-skilled and unskilled workers of Telangana.


    "The cost for development of infrastructure in the project is an estimated about Rs 16,784 crore. After the complete implementation of the project, it is expected to generate investments of about Rs 64,000 crore and provide direct and indirect employment to about 5,60,000 persons," the minister said.


    The Pharma City will come up over 19,000 acres in Ranga Reddy district.


    Read Also: China province eyeing investment opportunities in an Indian medical sector

    active pharmaceutical ingredientsHyderabadInvestmentsKT Rama Raooverwhelming responsepharmaPharma Citypharma companypharma newsRanga ReddyTelangana government
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok